These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21087193)

  • 1. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
    Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural characterization and in vitro cytotoxicity of new Au(III) and Au(I) complexes with thioamides.
    Kouroulis KN; Hadjikakou SK; Kourkoumelis N; Kubicki M; Male L; Hursthouse M; Skoulika S; Metsios AK; Tyurin VY; Dolganov AV; Milaeva ER; Hadjiliadis N
    Dalton Trans; 2009 Dec; (47):10446-56. PubMed ID: 20023866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
    Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
    Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
    Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
    Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural characterization and biological study of new organotin(IV), silver(I) and antimony(III) complexes with thioamides.
    Hadjikakou SK; Ozturk II; Xanthopoulou MN; Zachariadis PC; Zartilas S; Karkabounas S; Hadjiliadis N
    J Inorg Biochem; 2008; 102(5-6):1007-15. PubMed ID: 18279959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed ligand-silver(I) complexes with anti-inflammatory agents which can bind to lipoxygenase and calf-thymus DNA, modulating their function and inducing apoptosis.
    Banti CN; Giannoulis AD; Kourkoumelis N; Owczarzak AM; Poyraz M; Kubicki M; Charalabopoulos K; Hadjikakou SK
    Metallomics; 2012 Jun; 4(6):545-60. PubMed ID: 22552402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
    Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
    Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
    Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological studies of new organotin(IV) complexes of thioamide ligands.
    Xanthopoulou MN; Hadjikakou SK; Hadjiliadis N; Milaeva ER; Gracheva JA; Tyurin VY; Kourkoumelis N; Christoforidis KC; Metsios AK; Karkabounas S; Charalabopoulos K
    Eur J Med Chem; 2008 Feb; 43(2):327-35. PubMed ID: 17509733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
    Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
    J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
    Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
    Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fluxional amine gold(III) complex as an excellent catalyst and precursor of biologically active acyclic carbenes.
    Montanel-Pérez S; Herrera RP; Laguna A; Villacampa MD; Gimeno MC
    Dalton Trans; 2015 May; 44(19):9052-62. PubMed ID: 25893402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, characterization, and binding properties towards CT-DNA and lipoxygenase of mixed-ligand silver(I) complexes with 2-mercaptothiazole and its derivatives and triphenylphosphine.
    Kyros L; Banti CN; Kourkoumelis N; Kubicki M; Sainis I; Hadjikakou SK
    J Biol Inorg Chem; 2014 Mar; 19(3):449-64. PubMed ID: 24445998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
    Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
    J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
    Castiñeiras A; Dehnen S; Fuchs A; García-Santos I; Sevillano P
    Dalton Trans; 2009 Apr; (15):2731-9. PubMed ID: 19333496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
    J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
    Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
    Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold(I) triphenylphosphine complexes incorporating pentaarylfulleride ligands.
    Halim M; Kennedy RD; Khan SI; Rubin Y
    Inorg Chem; 2010 May; 49(9):3974-6. PubMed ID: 20377195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.